Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Samuel Kyei | Health Professions | Best Researcher Award

Published on by Shen Awards

Mr. Samuel Kyei | Health Professions | Best Researcher Award

PhD student of UNIVERSITY OF THE WEST OF ENGLAND, United Kingdom.

Mr. Samuel Kyei Baffour is a dedicated Public Health Specialist and Lecturer whose research focuses on the impact of greenspaces on student mental health. Currently pursuing a PhD at the University of the West of England, his work is highly relevant and timely, addressing key issues in public health and education. Samuel has extensive experience in data analysis and public health program facilitation, showcasing robust analytical and critical thinking skills. He has held roles as a Lecturer at Global Banking School and an Associate Lecturer at UWE Bristol, demonstrating his commitment to teaching and research. His achievements include securing significant funding, publishing research, and presenting at various conferences. Samuel’s leadership roles, such as the International Students’ Officer at the University of Worcester, highlight his organizational and advocacy skills. His diverse experience and contributions to public health research make him a notable candidate for the Best Researcher Award.

Profile
Education

Mr. Samuel Kyei holds a diverse educational background that reflects his commitment to public health and research. He is currently pursuing a PhD in Built and Natural Environment at the University of the West of England, focusing on maximizing the benefits of green spaces to enhance student mental health. Prior to this, he completed an MSc in Public Health at the University of Worcester, where he explored Black African international students’ experiences with physical activity. His foundational education includes a BSc (Hons) in Biological Sciences Education from the University of Education, Winneba, Ghana, where he studied various biological and environmental sciences. This extensive academic training has equipped Mr. Kyei with a solid understanding of public health, research methodologies, and environmental factors impacting well-being, underpinning his current research and professional endeavors.

Professional Experience

Mr. Samuel Kyei has a distinguished professional background encompassing diverse roles in academia and public health. As a Lecturer in Health Wellbeing and Social Care at Global Banking School, he is responsible for delivering and assessing coursework, developing materials, and engaging in student support activities. Concurrently, as an Associate Lecturer at the University of the West of England (UWE), he teaches environmental challenges and quantitative research methods while supervising MSc dissertations. His research role at UWE involved a critical literature review on nature-based solutions’ impact on health. Additionally, he serves as a Data and Insight Officer at Severn Wye Energy Agency, developing data collection methods and producing reports. His past roles include International Students’ Officer at the University of Worcester and volunteer work in dementia care, showcasing his dedication to enhancing health and education through diverse professional experiences.

Research Interest

Mr. Samuel Kyei’s research interests are centered on the intersection of public health and environmental factors, with a particular focus on the impact of greenspaces on mental health. Currently, his PhD research explores how campus greenspaces can enhance students’ mental well-being, reflecting his commitment to addressing contemporary public health challenges. Samuel’s work aims to understand and maximize the benefits of natural environments in promoting psychological health, which is critical in today’s urbanized and often stressful academic settings. His research employs both quantitative and qualitative data analysis to uncover the nuances of how greenspaces influence mental health outcomes. In addition, Samuel’s interests extend to broader public health issues, including health promotion and protection, with previous work examining the physical activity experiences of Black African international students in the UK. His multidisciplinary approach underscores his dedication to fostering holistic improvements in health and well-being.

Research Skills

Mr. Samuel Kyei possesses exceptional research skills marked by a robust analytical capability and a profound understanding of both qualitative and quantitative methodologies. His expertise includes proficient data analysis, utilizing tools such as SPSS, Stata, and Minitab to extract meaningful insights from complex datasets. Samuel’s research prowess is further evidenced by his critical literature reviews, report writing, and presentation of findings to industry stakeholders. His ability to manage and analyze data effectively is complemented by his experience in facilitating public health programs and conducting impactful research on mental health and greenspaces. Additionally, his experience as a Research Associate, Data and Insight Officer, and Lecturer demonstrates his aptitude for conducting thorough research, contributing to scholarly publications, and engaging in high-level academic discussions. Samuel’s commitment to research excellence is supported by his extensive training and leadership roles within academic and professional settings.

 Awards and Recognition

Mr. Samuel Kyei has garnered significant recognition for his contributions to public health and research. He has been awarded a full PhD studentship by the University of the West of England, covering fees and stipend for 3.5 years, and received the Commonwealth Shared Scholarship for his master’s studies. His dedication to advancing public health is further exemplified by a £500 conference travel grant from the Behavioural Science and Public Health Network. Notably, Mr. Kyei has also been honored with the Dean’s Excellence Award for outstanding academic performance during his undergraduate studies. His leadership and impact extend beyond academia, having been acknowledged for his roles in various student and professional capacities, including his position as an International Students’ Officer. These accolades underscore his commitment to research excellence and his influence in the field of public health.

Conclusion

Kyei Baffour Samuel demonstrates significant strengths as a researcher with a clear focus on improving student mental health through environmental factors. His innovative research, teaching experience, leadership roles, and recognition through awards and funding highlight his dedication and potential in the field of public health. To further enhance his profile for the Best Researcher Award, Samuel could focus on expanding his research impact, increasing publication volume, and fostering broader collaborations. Overall, his achievements and contributions make him a strong candidate for recognition.

Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Published on by Shen Awards

Dr. Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Surgery Resident and Fleni, Argentina.

Dr. Mariano Marrodan, MD, MSc, is a distinguished neurologist based in Buenos Aires, Argentina, with a robust background in neuroimmunology and multiple sclerosis. Currently, he serves as a Staff Neurologist at Fleni and Hospital Zonal General de Agudos Domingo Mercante. Dr. Marrodan holds a Master’s in Neuroimmunology from Universidad Autónoma de Barcelona and has completed notable fellowships at Cemcat and FLENI. His clinical research focuses on multiple sclerosis, autoimmune encephalitis, and neuroimmunology, with significant contributions to the understanding of Susac Syndrome and neuromyelitis optica spectrum disorders. He has published extensively in prestigious journals and is actively involved in mentoring and teaching, including directing neuroimmunology courses and coordinating virtual neuroimmunology rounds. Dr. Marrodan’s work, recognized through various awards, showcases his impact on advancing neurological research and improving patient care in Argentina and beyond.

Profile

Education

Dr. Mariano Marrodan’s educational background is distinguished by rigorous training and specialization in neurology and neuroimmunology. He earned his medical degree from Austral University in Buenos Aires, Argentina, graduating with honors in 2014. Following this, Dr. Marrodan completed his Neurology Residency at the Institute for Neurological Research Raul Carrea – FLENI from 2014 to 2018. His pursuit of specialized knowledge led him to a Clinical Fellowship in Multiple Sclerosis and Neuroimmunology at FLENI, which he completed in 2021. To further deepen his expertise, he pursued a Master’s in Neuroimmunology at the Universidad Autónoma de Barcelona (UAB), Spain, from 2022 to 2023. Additionally, he undertook a Multiple Sclerosis Research Fellowship at the Centre d’Esclerosi Múltiple de Catalunya (Cemcat) in Barcelona during the first half of 2023, augmenting his skills in advanced neuroimmunological research.

Professional Experience

Dr. Mariano Marrodan is a distinguished neurologist with extensive professional experience in both clinical and academic settings. Currently, he serves as a Staff Neurologist at Fleni in Buenos Aires, where he is involved in general neurology and the division of Multiple Sclerosis and Neuroimmunology. His role at Fleni began in June 2021 and includes contributions to inpatient services and specialized neuroimmunology care. Additionally, Dr. Marrodan works at Hospital Zonal General de Agudos Domingo Mercante and has held various roles at Fleni, including Junior Attending and Emergency Department Neurologist. His prior experience includes serving as a Staff Neurologist at the neurological rehabilitation center “La Horqueta” and as Neurology Chief Resident at FLENI. Dr. Marrodan’s background reflects a strong commitment to advancing neurology through clinical practice, research, and education.

Research Interests

Dr. Mariano Marrodan’s research focuses on advancing our understanding of neuroimmunological and neurodegenerative diseases, particularly Multiple Sclerosis (MS) and related conditions. His work emphasizes the pathophysiology, diagnostic strategies, and treatment outcomes of MS and neuromyelitis optica spectrum disorders (NMOSD). Dr. Marrodan is particularly interested in exploring the impact of novel therapeutic approaches and assessing their efficacy in real-world settings. His research involves extensive clinical and observational studies, such as evaluating the effects of oral Cladribine on MRI lesions in MS patients and developing a Latin-American database for Susac Syndrome. He is also engaged in the International MS Microbiome Study and the Argentinean Multiple Sclerosis Registry, which aim to deepen the understanding of disease mechanisms and treatment responses. Through his innovative research, Dr. Marrodan seeks to improve patient care and contribute to the global knowledge base on neuroimmunological disorders.

Research Skills

Dr. Mariano Marrodan exhibits exceptional research skills across multiple dimensions of neurology. His expertise spans clinical and basic research, with a notable focus on multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis. Dr. Marrodan excels in designing and conducting observational and interventional studies, such as his principal investigator role in studies on oral Cladribine and Susac Syndrome. His proficiency extends to statistical analysis and study design, evidenced by his involvement in large-scale registries and multicentric collaborations. Dr. Marrodan’s adeptness in using advanced diagnostic tools, including MRI and immunological assessments, complements his strong publication record in high-impact journals. His leadership in coordinating neuroimmunology courses and mentoring junior researchers further underscores his commitment to advancing knowledge and fostering scientific growth. Dr. Marrodan’s multifaceted research skills make him a distinguished contributor to the field of neurology.

Awards and Recognition 🏆

Dr. Marrodan has received recognition through his roles in prestigious research projects and his contributions to significant publications. His continued involvement in high-profile academic and clinical roles indicates a respected position within his field.

Conclusion 🏅

Dr. Mariano Marrodan’s extensive research contributions, collaborative efforts, and applied clinical research make him a compelling candidate for the Best Researcher Award. His work not only advances the field of neurology but also impacts clinical practice and patient outcomes on a regional and global scale.

Publications Top Notes

  • Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
    • Authors: Carnero Contentti, E., Lopez, P.A., Patrucco, L., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
  • Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Caride, A., Rojas, J.I.
    • Year: 2024
  • Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
    • Authors: Pestchanker, C., Bertado Cortez, B., Lana Peixoto, M.A., Lopez, P., Carnero Contentti, E.
    • Year: 2024
  • Selection of disease modifying therapies in multiple sclerosis based on patient’s age and disease activity: Data from a nationwide registry
    • Authors: Piedrabuena, M.A., Correale, J., Fiol, M., Martinez, C.M., Ysrraelit, M.C.
    • Year: 2024
  • Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    • Authors: Camerlingo, S., Rubinstein, F., Celia Ysrraelit, M., Silva, B.A., Alonso, R.
    • Year: 2024
    • Citations: 1
  • Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
    • Authors: Carnero Contentti, E., López, P.A., Pappolla, A., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
    • Citations: 1
  • Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
    • Authors: Marrodan, M., Calandri, I.L., Bocancea, D.I., Fiol, M.P., Correale, J.
    • Year: 2024
  • Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 4
  • Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome
    • Authors: Plantone, D., Sabatelli, E., Locci, S., De Stefano, N., Iorio, R.
    • Year: 2023
    • Citations: 2
  • Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
    • Authors: Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 3

 

Farzad Shidfar | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Farzad Shidfar | Health Professions | Best Researcher Award

Faculty Member at Iran University of Medical Sciences, Iran

Professor Farzad Shidfar is a distinguished academic in the field of nutrition, currently serving at the Iran University of Medical Sciences. With a robust educational background, including a Ph.D. in Nutrition from Tehran University of Medical Sciences, he has made significant contributions to the field through his research. His work spans a range of topics including dietary impacts on chronic diseases, the effects of various supplements, and the management of irritable bowel syndrome and cardiovascular risk factors. Professor Shidfar has published extensively, with recent studies focusing on the impact of FODMAP diets, ellagic acid supplementation, and the role of probiotics. His research has been influential in understanding nutritional interventions and their effects on health outcomes. His extensive publication record and contributions to clinical trials reflect his commitment to advancing nutritional science and improving public health.

Professional Profile

Education

Professor Farzad Shidfar’s educational background reflects a strong foundation in nutrition and health sciences. He earned his Bachelor’s degree in Nutrition from Isfahan University of Medical Sciences, Isfahan, Iran, in 1993. Building on this, he pursued a Master’s degree in Nutrition at Tabriz University of Medical Sciences, Tabriz, Iran, which he completed in 1996. His academic journey culminated with a Ph.D. in Nutrition from Tehran University of Medical Sciences, Tehran, Iran, in 2002. Professor Shidfar’s extensive educational training equips him with a deep understanding of nutritional science, allowing him to contribute significantly to research and academic discourse in the field. His advanced degree in English further complements his scholarly activities, enabling effective communication and collaboration within the global scientific community.

Professional Experience

Professor Farzad Shidfar is a distinguished academic in the field of nutrition, currently serving at the Department of Nutrition, School of Health, Iran University of Medical Sciences. He earned his Bachelor’s degree in Nutrition from Isfahan University of Medical Sciences in 1993, a Master’s in Nutrition from Tabriz University of Medical Sciences in 1996, and a Ph.D. in Nutrition from Tehran University of Medical Sciences in 2002. His extensive career includes significant contributions to the study of dietary impacts on health, with a focus on managing conditions such as irritable bowel syndrome, ulcerative colitis, and cardiovascular diseases. Professor Shidfar has led numerous clinical trials and systematic reviews, addressing various aspects of nutrition and its effects on health. His work is widely published in peer-reviewed journals, demonstrating his expertise and commitment to advancing knowledge in the field of nutrition.

Research Interest

Professor Farzad Shidfar’s research interests lie predominantly in nutrition and its impact on various health conditions. His work focuses on dietary interventions and their effects on chronic diseases such as irritable bowel syndrome, multiple sclerosis, and ulcerative colitis. He explores the influence of specific nutrients and dietary patterns on inflammation, oxidative stress, and neuroprotection. His research extends to examining the role of supplements like ellagic acid, berberine, and selenium in managing disease activity and improving patient outcomes. Professor Shidfar is also deeply involved in evaluating the efficacy of dietary strategies for cardiovascular risk reduction and the modulation of metabolic syndrome. His extensive publications reflect his commitment to advancing our understanding of nutritional science and its practical applications in health and disease management.

Research Skills

Professor Farzad Shidfar possesses a broad and deep skill set in nutrition research, underscoring his significant contributions to the field. His expertise includes systematic reviews and meta-analyses, as evidenced by his comprehensive evaluations of dietary impacts on health conditions such as irritable bowel syndrome, multiple sclerosis, and cardiovascular risk factors. Professor Shidfar is adept at conducting randomized controlled trials, as demonstrated in his studies on the effects of dietary supplements and functional foods on various health outcomes. His proficiency in statistical analysis and data interpretation enables him to draw meaningful conclusions from complex datasets, supporting evidence-based dietary recommendations. Additionally, his experience extends to interdisciplinary research, collaborating with experts across fields to address global health issues. Professor Shidfar’s ability to integrate applied research with practical applications highlights his commitment to advancing nutritional science and improving public health outcomes.

Awards and Recognition

Professor Shidfar’s achievements in research have been recognized through various awards and honors. His publications in high-impact journals and his contributions to multiple clinical trials and systematic reviews attest to his standing in the scientific community. His work not only advances the field of nutrition but also impacts public health policies and practices.

Conclusion

In conclusion, Professor Farzad Shidfar is a highly accomplished researcher with significant contributions to nutrition and health sciences. His extensive research, collaborative efforts, and applied focus make him a strong candidate for the Research for Women Researcher Award. His work addresses critical health issues, spans a wide geographic impact, and intersects with broader environmental and public health concerns.

Publications Top Notes

  • Ultra-Processed food intake and risk of Helicobacter pylori infection: A case–control study
    • Authors: Z. Ebrahimi, Z. Shateri, M. Nouri, F. Shidfar, M. Hejazi
    • Journal: Food Science and Nutrition
    • Volume: 12(7)
    • Pages: 5019–5026
    • Year: 2024
  • Effects of a low FODMAP diet on the symptom management of patients with irritable bowel syndrome: a systematic umbrella review with the meta-analysis of clinical trials
    • Authors: M. Khalighi Sikaroudi, S. Soltani, S.M. Ghoreishy, F. Shidfar, A. Dehnad
    • Journal: Food and Function
    • Volume: 15(10)
    • Pages: 5195–5208
    • Year: 2024
  • Assessment of the anti-inflammatory and anti-glycemic properties of Royal Jelly and Tocotrienol-rich fraction in an experimental study: Does irisin mediate these effects?
    • Authors: N. Mesri Alamdari, P. Irandoost, N. Roshanravan, H. AmirAzad, F. Shidfar
    • Journal: Food Science and Nutrition
    • Year: 2024
  • The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-blind, placebo-controlled trial
    • Authors: G. Hajiluian, S.J. Karegar, F. Shidfar, J. Heshmati, A.-A. Delbandi
    • Journal: Phytomedicine
    • Volume: 121
    • Article: 155094
    • Year: 2023
    • Citations: 7
  • The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial
    • Authors: Y. Khazaei, A. Basi, M.L. Fernandez, R. Bagherzadeh, F. Shidfar
    • Journal: BMC Complementary Medicine and Therapies
    • Volume: 23(1)
    • Article: 339
    • Year: 2023
    • Citations: 6
  • Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose–response meta-analysis of randomized clinical trials
    • Authors: Y. Vahedi-Mazdabadi, H. Shahinfar, M. Toushih, F. Shidfar
    • Journal: Phytotherapy Research
    • Volume: 37(12)
    • Pages: 5541–5557
    • Year: 2023
    • Citations: 5
  • The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial
    • Authors: M. Khazdouz, N.E. Daryani, M. Cheraghpour, S.B. Ghavami, F. Shidfar
    • Journal: European Journal of Nutrition
    • Volume: 62(8)
    • Pages: 3125–3134
    • Year: 2023
    • Citations: 3
  • Comparison of predictive effect of the dietary inflammatory index and empirically derived food-based dietary inflammatory index on the menopause-specific quality of life and its complications
    • Authors: N. Haghshenas, F.H. Baharanchi, E. Melekoglu, M.H. Sohouli, F. Shidfar
    • Journal: BMC Women’s Health
    • Volume: 23(1)
    • Article: 349
    • Year: 2023
    • Citations: 1
  • The effects of melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial
    • Authors: M. Safari, A. Asadi, N. Aryaeian, A.F. Hosseini, Z. Hamidi
    • Journal: BMC Complementary Medicine and Therapies
    • Volume: 23(1)
    • Article: 140
    • Year: 2023
    • Citations: 8
  • The effects of aqueous and ethanolic extracts of Rheum ribes on insulin-resistance and apolipoproteins in patients with type 2 diabetes mellitus: a randomized controlled trial
    • Authors: A. Ghafouri, S. Jafari Karegar, G. Hajiluian, I. Heydari, F. Shidfar
    • Journal: BMC Complementary Medicine and Therapies
    • Volume: 23(1)
    • Article: 46
    • Year: 2023
    • Citations: 2